These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37039880)

  • 1. Age and sex differences in the risk of cardiovascular diseases by chronic kidney disease in a general Japanese population.
    Shiraishi YA; Ishikawa Y; Ishikawa J; Matsumura M; Ishikawa S
    Heart Vessels; 2023 Sep; 38(9):1164-1171. PubMed ID: 37039880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Chen Y; Zelnick LR; Huber MP; Wang K; Bansal N; Hoofnagle AN; Paranji RK; Heckbert SR; Weiss NS; Go AS; Hsu CY; Feldman HI; Waikar SS; Mehta RC; Srivastava A; Seliger SL; Lash JP; Porter AC; Raj DS; Kestenbaum BR;
    Am J Kidney Dis; 2021 Aug; 78(2):226-235.e1. PubMed ID: 33421453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
    Meisinger C; Döring A; Löwel H;
    Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study.
    Hirata A; Okamura T; Sugiyama D; Kuwabara K; Kadota A; Fujiyoshi A; Miura K; Okuda N; Ohkubo T; Okayama A; Ueshima H;
    Eur J Prev Cardiol; 2017 Mar; 24(5):505-513. PubMed ID: 27856810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
    McCullough PA; Li S; Jurkovitz CT; Stevens L; Collins AJ; Chen SC; Norris KC; McFarlane S; Johnson B; Shlipak MG; Obialo CI; Brown WW; Vassalotti J; Whaley-Connell AT; Brenner RM; Bakris GL;
    Am Heart J; 2008 Aug; 156(2):277-83. PubMed ID: 18657657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light wine consumption is associated with a lower odd for cardiovascular disease in chronic kidney disease.
    Jespersen T; Kruse N; Mehta T; Kuwabara M; Noureddine L; Jalal D
    Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1133-1139. PubMed ID: 30143406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trials.
    Sacre JW; Magliano DJ; Shaw JE
    Diabetes Metab; 2021 Sep; 47(5):101249. PubMed ID: 33744399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study.
    Toth-Manikowski SM; Yang W; Appel L; Chen J; Deo R; Frydrych A; Krousel-Wood M; Rahman M; Rosas SE; Sha D; Wright J; Daviglus ML; Go AS; Lash JP; Ricardo AC;
    Am J Kidney Dis; 2021 Aug; 78(2):200-209.e1. PubMed ID: 33857532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultraprocessed Foods and Kidney Disease Progression, Mortality, and Cardiovascular Disease Risk in the CRIC Study.
    Sullivan VK; Appel LJ; Anderson CAM; Kim H; Unruh ML; Lash JP; Trego M; Sondheimer J; Dobre M; Pradhan N; Rao PS; Chen J; He J; Rebholz CM;
    Am J Kidney Dis; 2023 Aug; 82(2):202-212. PubMed ID: 37028638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients.
    Ducluzeau PH; Fauchier G; Herbert J; Semaan C; Halimi JM; Angoulvant D; Fauchier L
    Diabetes Metab; 2023 May; 49(3):101429. PubMed ID: 36736892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race.
    Hui X; Matsushita K; Sang Y; Ballew SH; Fülöp T; Coresh J
    Am J Kidney Dis; 2013 Oct; 62(4):691-702. PubMed ID: 23769137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study.
    Gooden TE; Gardner M; Wang J; Jolly K; Lane DA; Benjamin LA; Mwandumba HC; Kandoole V; Lwanga IB; Taylor S; Manaseki-Holland S; Lip GYH; Nirantharakumar K; Thomas GN
    J Infect Dis; 2022 Apr; 225(8):1348-1356. PubMed ID: 34417792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study.
    Kokubo Y; Nakamura S; Okamura T; Yoshimasa Y; Makino H; Watanabe M; Higashiyama A; Kamide K; Kawanishi K; Okayama A; Kawano Y
    Stroke; 2009 Aug; 40(8):2674-9. PubMed ID: 19478215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
    J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.
    Matsushita K; Sang Y; Ballew SH; Astor BC; Hoogeveen RC; Solomon SD; Ballantyne CM; Woodward M; Coresh J
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1770-7. PubMed ID: 24876355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Renal Function Trajectories and Long-Term Cardiovascular Risks Among a Population Without Chronic Kidney Disease.
    Zhai YS; Cheng YJ; Deng HW; Li J; Peng L; Gao X
    J Am Heart Assoc; 2023 Apr; 12(8):e028556. PubMed ID: 37042265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
    Schlackow I; Kent S; Herrington W; Emberson J; Haynes R; Reith C; Wanner C; Fellström B; Gray A; Landray MJ; Baigent C; Mihaylova B;
    Heart; 2017 Dec; 103(23):1880-1890. PubMed ID: 28780579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular events and death in Japanese patients with chronic kidney disease.
    Tanaka K; Watanabe T; Takeuchi A; Ohashi Y; Nitta K; Akizawa T; Matsuo S; Imai E; Makino H; Hishida A;
    Kidney Int; 2017 Jan; 91(1):227-234. PubMed ID: 27884399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.